StockNews.AI
OGN
StockNews.AI
43 days

Organon & Co. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 22, 2025 to Discuss Your Rights – OGN

1. Class action filed against Organon for misleading statements to investors. 2. 45% drop in regular dividend concealed amid a debt reduction strategy. 3. Organon’s stock plummeted over 27% following misleading dividend information.

4m saved
Insight
Article

FAQ

Why Bearish?

The class action lawsuit reflects severe investor trust issues due to misleading information, and the significant drop in share price reinforces negative investor sentiment.

How important is it?

The misleading statements and subsequent dividend reduction significantly affect shareholder confidence, influencing OGN's market perception and value.

Why Short Term?

Immediate impact felt after the lawsuit announcement, potentially influencing OGN’s price in the coming weeks.

Related Companies

DERMMRNAPFE
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=155431&from=3 CLASS PERIOD: October 31, 2024 to April 30, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Organon’s priorities, particularly, related to capital allocation through quarterly dividends. Notably, defendants concealed the high priority of Organon’s debt reduction strategy following the Company’s acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Following this news, the price of Organon’s common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon’s stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day. DEADLINE: July 22, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=155431&from=3 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of OGN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 22, 2025. There is no cost or obligation to you to participate in this case. WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (646) 453-8903

Related News